Innoviva
INVA
#5098
Rank
A$2.37 B
Marketcap
A$31.80
Share price
1.63%
Change (1 day)
6.17%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): A$0.23 Billion

According to Innoviva's latest financial reports the company's current earnings are A$0.38 Billion. In 2024 the company made an earning of A$56.4 Million a decrease over its 2023 earnings that were of A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.23 B318.76%
2024 A$56.4 M-80.74%
2023 A$0.29 B-32.36%
2022 A$0.43 B-35.56%
2021 A$0.67 B25.7%
2020 A$0.53 B52.11%
2019 A$0.35 B10.77%
2018 A$0.31 B56.59%
2017 A$0.20 B125.53%
2016 A$89.82 M-417.36%
2015 -A$28.31 Million-74.49%
2014 -A$0.12 Billion-25.19%
2013 -A$0.15 Billion430.06%
2012 -A$27.98 Million-83.92%
2011 -A$0.18 Billion39.82%
2010 -A$0.13 Billion2.84%
2009 -A$0.13 Billion-8.62%
2008 -A$0.14 Billion-47.92%
2007 -A$0.26 Billion-5.92%
2006 -A$0.28 Billion19.8%
2005 -A$0.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.4 Million-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.25 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA